Covid19
Early Promise for PCSK9 Inhibition in Severe COVID-19 | MedPage Today
Among people with severe COVID-19 with respiratory failure and heightened inflammation, the advantage of getting PCSK9 inhibition therapy was a …
Among people with severe COVID-19 with respiratory failure and heightened inflammation, the advantage of getting PCSK9 inhibition therapy was a …